Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Database
Language
Publication year range
1.
J Virol ; 64(1): 401-5, 1990 Jan.
Article in English | MEDLINE | ID: mdl-1688385

ABSTRACT

A recombinant bovine leukemia virus (BLV) was constructed in which the X region was replaced with the bacterial neomycin resistance gene controlled by the simian virus 40 early promoter. This virus, termed BLV-SVNEO, is a self-packaging, activator-dependent retroviral vector. Introduction of the plasmid pBLV-SVNEO into mammalian cells resulted in constitutive expression of the neo gene, whereas the BLV structural genes, gag, pol, and env, were expressed only in the presence of the two regulatory proteins, Tax and Rex. The production and release of recombinant virus by cells transfected with pBLV-SVNEO were proportional to the number of G418-resistant colonies that developed after susceptible cells were exposed to the filtered culture medium. BLV-SVNEO was able to infect cell lines of human, bovine, canine, feline, and murine origin. BLV-producing cell lines were resistant to superinfection with BLV-SVNEO. This cell-virus system should facilitate molecular genetic studies of BLV and will provide a rapid, quantitative measure of BLV infectivity in a variety of cell types. These studies also demonstrate the feasibility of using activator-dependent retroviral vectors such as BLV-SVNEO to deliver foreign genes into cells and eventually animals.


Subject(s)
Genetic Vectors , Leukemia Virus, Bovine/genetics , Recombination, Genetic , Retroviridae/genetics , Animals , Cell Line , Drug Resistance, Microbial/genetics , Gene Expression , Genes, Viral , Leukemia Virus, Bovine/pathogenicity , Neomycin/pharmacology , Promoter Regions, Genetic , RNA, Viral/genetics , RNA, Viral/isolation & purification , RNA-Directed DNA Polymerase , Simian virus 40/genetics , Transcription, Genetic , Transfection
2.
J Virol ; 65(7): 3460-7, 1991 Jul.
Article in English | MEDLINE | ID: mdl-1645777

ABSTRACT

The structural regions that comprise the functional domains of lentivirus Tat proteins were examined. Chimeric tat genes and chimeric viral promoters were constructed between the distantly related human immunodeficiency virus type 1 (HIV-1) and equine infectious anemia virus (EIAV). These exchange experiments revealed that the EIAV Tat-responsive element recognition domain is formed by two distinct structural regions. Activation domains of both HIV-1 and EIAV Tat contain a conserved core element, but at least HIV-1 Tat requires the presence of additional structural regions. The interchangeable nature of Tat activation domains suggests that these domains act through a common or ubiquitous cellular transcription factor.


Subject(s)
Gene Products, tat/genetics , HIV-1/genetics , Infectious Anemia Virus, Equine/genetics , Lentivirus/genetics , Amino Acid Sequence , Cloning, Molecular , DNA Mutational Analysis , Gene Expression Regulation, Viral , HIV Long Terminal Repeat/genetics , Molecular Sequence Data , Promoter Regions, Genetic , Recombinant Fusion Proteins , Regulatory Sequences, Nucleic Acid , Restriction Mapping , Structure-Activity Relationship , Transcriptional Activation , tat Gene Products, Human Immunodeficiency Virus
3.
J Virol ; 64(4): 1616-24, 1990 Apr.
Article in English | MEDLINE | ID: mdl-2157047

ABSTRACT

Equine infectious anemia virus (EIAV) contains a tat gene which is closely related to the trans-activator genes of the human and simian immunodeficiency viruses. Nucleotide sequence analysis of EIAV cDNA clones revealed that the tat mRNA is composed of three exons; the first two encode Tat and the third may encode a Rev protein. Interestingly, EIAV Tat translation is initiated at a non-AUG codon in exon 1 of the mRNA, perhaps allowing an additional level of gene regulation. The deduced amino acid sequence of EIAV tat, combined with functional analyses of tat cDNAs in transfected cells, has provided some unique insights into the domain structure of Tat. EIAV Tat has a C-terminal basic domain and a highly conserved 16-amino-acid core domain, but not the cysteine-rich region, that are present in the primate immunodeficiency virus Tat proteins. Thus, EIAV encodes a relatively simple version of this kind of trans activator.


Subject(s)
Biological Evolution , Gene Products, tat/genetics , Infectious Anemia Virus, Equine/genetics , Trans-Activators/genetics , Amino Acid Sequence , Animals , Base Sequence , Cells, Cultured , Cloning, Molecular , Codon , DNA, Viral/genetics , Exons , Gene Products, tat/biosynthesis , Humans , Molecular Sequence Data , Retroviridae/genetics , Structure-Activity Relationship
4.
Dev Biol Stand ; 72: 39-48, 1990.
Article in English | MEDLINE | ID: mdl-2178129

ABSTRACT

Equine infectious anemia virus (EIAV) encodes a tat gene which is closely related to the trans-activators encoded by the human and simian immunodeficiency viruses. Nucleotide sequence analysis of EIAV cDNA clones revealed that the tat message is composed of three exons; the first two encode tat and the third may encode rev.. Interestingly, EIAV tat translation is initiated at a non-AUG codon in the first exon of the message, perhaps allowing an additional level of gene regulation. The deduced amino acid sequence of EIAV tat, combined with functional analyses of tat cDNAs in transfected cells, have provided some unique insights into the domain structure of this protein. EIAV Tat has a C-terminal basic domain, a highly conserved 16 amino acid core domain, but not the cysteine-rich region, that is present in the primate immunodeficiency virus Tat proteins. Thus EIAV encodes a relatively simple version of this kind of trans-activator.


Subject(s)
DNA, Viral/genetics , Gene Expression Regulation, Viral , Gene Products, tat/genetics , Genes, tat , Infectious Anemia Virus, Equine/genetics , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cell Line , Cloning, Molecular , Exons , Gene Products, tat/chemistry , Molecular Sequence Data , Open Reading Frames , Protein Biosynthesis , RNA, Viral/genetics , Restriction Mapping , Transcription, Genetic , Transcriptional Activation , Transfection
5.
J Virol ; 68(5): 3102-11, 1994 May.
Article in English | MEDLINE | ID: mdl-8151775

ABSTRACT

The cis- and trans-acting components of the Rev regulatory pathway employed by equine infectious anemia virus (EIAV) to regulate and coordinate viral gene expression were examined in complementation experiments. Viral protein expression and mRNA expression were compared in cells transiently transfected with wild-type or mutant proviruses in combination with Rev expression plasmids. Mutation of the predicted rev gene abolished Gag protein synthesis, and this defect was complemented, in trans, by Rev. Analysis of viral mRNAs from transfected cells confirmed that EIAV expresses five major mRNAs: the full-length and singly spliced mRNAs contain introns and encode viral structural proteins while the three fully spliced mRNAs, encoding nonstructural genes, are generated by alternative splicing. Compared to cells transfected with the wild-type provirus, the intron-containing mRNAs produced from the rev-minus mutant were present at reduced levels in the nuclear RNA fraction and were not detected in the cytoplasm. This pattern of viral mRNA synthesis was restored to the wild-type pattern by providing Rev in trans. In contrast to the intron-containing mRNAs, cytoplasmic accumulation of the multiply spliced class of mRNAs was independent of Rev. Closer examination of the multiply spliced class of viral mRNAs by reverse transcriptase-PCR analysis revealed a Rev-dependent alternative splicing phenomenon. In the absence of Rev, proviruses expressed a four-exon mRNA at high levels; the addition of Rev caused both a decrease in the levels of the four-exon mRNA and the appearance of a related mRNA lacking exon 3. The cis-acting RNA elements that mediate Rev responsiveness were studied with deleted proviruses, which revealed that EIAV contains at least two elements located near the ends of envelope gene. Unlike the Rev-responsive elements in other retroviruses, the cis-acting regions of EIAV do not appear to form complex secondary structures.


Subject(s)
Alternative Splicing/drug effects , Gene Products, rev/pharmacology , Infectious Anemia Virus, Equine/genetics , RNA, Messenger/metabolism , RNA, Viral/metabolism , Animals , Base Sequence , Blotting, Northern , DNA Mutational Analysis , DNA, Complementary/genetics , Exons/genetics , Gene Products, gag/biosynthesis , Genetic Complementation Test , Molecular Sequence Data , Plasmids/genetics , Polymerase Chain Reaction , Proviruses/genetics , Recombinant Proteins/pharmacology , Regulatory Sequences, Nucleic Acid/genetics
SELECTION OF CITATIONS
SEARCH DETAIL